The invention providesa tumor cell genetically modifiedto express a nucleic acid encodinga secreted form of a heat shockprotein (hsp) gp96 polypeptide. Theinvention also provides a method ofstimulating an immune response to atumor by administering a tumor cellgenetically modified to express anucleic acid encoding a secreted formof a gp96 polypeptide.